Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
3.420
+0.060 (1.79%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Company Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.
It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories.
The company was founded in 2011 and is headquartered in Laguna Hills, California.
Adagio Medical Holdings, Inc.
| Country | United States |
| Founded | 2011 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 85 |
| CEO | Olav Bergheim |
Contact Details
Address: 26051 Merit Circle, Suite 102 Laguna Hills, California 92653 United States | |
| Phone | 949-348-1188 |
| Website | adagiomedical.com |
Stock Details
| Ticker Symbol | ADGM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002006986 |
| ISIN Number | US00534B1008 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Adam Leo Stone | Chief Executive Officer and Director |
| Michael Seth Altman | Chief Financial Officer and Director |
| Konstantin Poukalov | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 19, 2024 | EFFECT | Notice of Effectiveness |
| Sep 19, 2024 | EFFECT | Notice of Effectiveness |
| Sep 19, 2024 | 424B3 | Prospectus |
| Sep 19, 2024 | 424B3 | Prospectus |
| Sep 13, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Sep 13, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Aug 26, 2024 | 10-Q | Quarterly Report |
| Aug 19, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 8-K/A | [Amend] Current report |
| Aug 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |